Author

Anissa Martinez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:bacteria (other)· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Assay:protein sequence· 1

Frequent Co-Authors

Benjamin W. JesteriD· 2 shared Stacey Ertel· 2 shared Alexandria Taber· 1 shared Amanda Randolph· 1 shared Ashley Krzeszowski· 1 shared Babak AlipanahiiD· 1 shared Brian FinrowiD· 1 shared Brittney Robinett· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Benjamin W. JesterORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2

Christof Angermueller, Zelda Mariet, Benjamin W. Jester, Emily Engelhart, Ryan Emerson, Babak Alipanahi, Charles Lin, Colleen Shikany, Daniel Guion, Joel B. Nelson, Mary Kelley, Margot McMurray, Parker Shaffer, Cameron Cordray, Samer F. Halabiya, , Lucy J. Colwell

This study uses ML to design diverse VHH antibodies that neutralize SARS-CoV-1 and SARS-CoV-2 variants, including Delta and Omicron BA.1.

bioRxiv · Dec 1, 2023 · PreprintBioinformatics

Expression and Manufacturing of Protein Therapeutics in Spirulina

Benjamin W. Jester, Hui Zhao, Mesfin M. Gewe, Thomas Adame, Lisa Perruzza, David T. Bolick, Jan M. Agosti, Nhi Khuong, Rolf E. Kuestner, Caitlin Gamble, Kendra Cruickshank, Jeremy Ferrara, Rachelle Lim, Troy Paddock, Colin Brady, , James M. Roberts

This paper develops a genetic engineering platform in spirulina for producing bioactive protein therapeutics at scale, demonstrating its potential for low-cost biopharmaceutical manufacturing.

bioRxiv · Jan 25, 2021 · PreprintMolecular Biology